Clinical Trial Update: Daclizumab to Treat HIV-Infected Patients [Phase 1]

View source ↗

Summary

A Phase 1 study by NIAID evaluating daclizumab in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Daclizumab (daclizumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED